IGC Pharma, Inc. vs. Johnson & Johnson
IGC Pharma, Inc. and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| IGC | JNJ | |
|---|---|---|
| Market Cap | $20.54 million | $687.89 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| IGC | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.88% |
IGC and JNJ split the dividend factors evenly.
Risk & Sentiment
| IGC | JNJ | |
|---|---|---|
| Short Interest | 0.52% | 0.67% |
IGC leads on 1 of 1 risk & sentiment factors.
Dig deeper: IGC overview, IGC financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
